SEC Form 4 · accession 0001209191-18-059156
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Nov 15, 2018
Accepted (ET)
Nov 19, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 15, 2018 | S | 10,442 | $47.25 | D | 126,241 | D | |
| Common StockF3 | Nov 15, 2018 | S | 4,558 | $47.70 | D | 121,683 | D | |
| Common StockF4 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF4 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.57 to $47.56, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.57 to $47.975, inclusive.
- F4Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.